Prostate stents are medical devices used to keep open the space surrounding prostatic urethra and bladder neck in order to allow smooth urine flow in case of urine incontinence. These stents are effective in alleviating the bladder outlet obstruction resulted from benign prostatic hyperplasia (common among men aged above 70 years). However, a prostate stent should not be positioned too proximal to the external sphincter because it could cause urine incontinence. Other complications caused by prostate stents include risk of formation of bladder stones and granulation tissues. Additional formation of tissue surrounding the stent could obstruct the normal urine flow.
According to Scientific Reports, the global prevalence of benign prostatic hyperplasia was estimated at 26% in 2017 and it increases with age. The global prostate stents market is primarily driven by increase in cases of benign prostatic hyperplasia, diagnosis and treatment rates among men, preference for minimally invasive surgery, health care infrastructure, availability of prostate stents, and presence of major players. Stringent regulatory landscape and product recalls are likely to hamper the growth of the global prostate stents market during the forecast period. However, mergers and acquisitions among major players, increase in R&D investments by key manufacturers, and technological advancements are projected to drive the global prostate stents market in the next few years.
In terms of material type, the global prostate stents market can be segmented into metal, plastic, and others. Metal stents have significant advantages in the urology field. The risk of urethral injury is low when a metal stent is inserted by compressing it through the urethra.
Based on product type, the global prostate stents market can be bifurcated into permanent and temporary. Several studies have indicated that the use of permanent stents causes migration of stents and recurrence of urinary tract infections. Development of plastic stents could eliminate the problem of stent migration.
In terms of end-user, the global prostate stents market can be divided into hospitals, clinics, and others. The hospitals segment held the largest market share in 2017. The others segment includes home care and academic & research institutes.
Geographically, the global prostate stents market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the American Urological Association, benign prostatic hyperplasia is a common urologic abnormality in the U.S. and its incidence increases with age. North America held the largest share of the global prostate stents market in 2017, owing to significant incidence of benign prostatic hyperplasia among men, high diagnostic and treatment rates of benign prostatic hyperplasic, robust health care infrastructure, availability of health care re-imbursement for treatment of urological diseases in the U.S., presence of major players, and availability of prostate stents. Europe held the second largest market share in 2017 due to higher awareness about the outcomes of benign prostatic hyperplasia, presence of major companies, and availability of prostate stents. A study published in the World Journal of Urology in 2015 stated that older men in Europe with higher education, access to health care, and involved in medical services are more likely to self-report being diagnosed. Developing health care infrastructure, larger patient population, intense competition between domestic players and global players, and technological advancements are projected to drive the prostate stents market in Asia Pacific. High cost of prostate stents and underdeveloped health care infrastructure in Latin America and Middle East & Africa are likely to restrain the prostate stents market during the forecast period.
Major companies in the global prostate stents market are SRS Medical, Pnn Medical A/S, Boston Scientific, Allium Medical, and C. R. Bard (part of BD), among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.